颌骨缺损骨重建后骨密度变化的临床研究

注册号:

Registration number:

ChiCTR2300069661 

最近更新日期:

Date of Last Refreshed on:

2023-08-12 22:16:37 

注册时间:

Date of Registration:

2023-03-22 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

颌骨缺损骨重建后骨密度变化的临床研究

Public title:

The clinical research on the change of bone mineral density after the reconstruction of jaw

注册题目简写:

English Acronym:

研究课题的正式科学名称:

颌骨缺损骨重建后骨密度变化的临床研究

Scientific title:

The clinical research on the change of bone mineral density after the reconstruction of jaw

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

杨翊晖 

研究负责人:

单小峰 

Applicant:

Yang Yihui 

Study leader:

Shan Xiaofeng 

申请注册联系人电话:

Applicant telephone:

+86 13810088967

研究负责人电话:

Study leader's
telephone:

+86 10 82195158

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yttbjcn@163.com

研究负责人电子邮件:

Study leader's E-mail:

kqsxf@263.net

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市海淀区中关村南大街22号

研究负责人通讯地址:

北京市海淀区中关村南大街22号

Applicant address:

22 Zhongguancun Street South, Haidian District, Beijing

Study leader's address:

22 Zhongguancun Street South, Haidian District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京大学口腔医院

Applicant's institution:

Peking University School and Hospital of Stomatology

研究负责人所在单位:

北京大学口腔医院

Affiliation of the Leader:

Peking University School and Hospital of Stomatology

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

PKUSSIRB-202282159

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京大学口腔医院生物医学伦理委员会

Name of the ethic committee:

Ethics Committee of Peking University School and Hospital of Stomatology

伦理委员会批准日期:

Date of approved by ethic committee:

2022-12-29 00:00:00

伦理委员会联系人:

贾效伟

Contact Name of the ethic committee:

Jia Xiaowei

伦理委员会联系地址:

北京市海淀区中关村南大街22号

Contact Address of the ethic committee:

22 Zhongguancun Street South, Haidian District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京大学口腔医院

Primary sponsor:

Peking University School and Hospital of Stomatology

研究实施负责(组长)单位地址:

北京市海淀区中关村南大街22号

Primary sponsor's address:

22 Zhongguancun Street South, Haidian District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

海淀

Country:

China

Province:

Beijing

City:

Haidian

单位(医院):

北京大学口腔医院

具体地址:

北京市海淀区中关村南大街22号

Institution
hospital:

Peking University School and Hospital of Stomatology

Address:

22 Zhongguancun Street South, Haidian District, Beijing

经费或物资来源:

Source(s) of funding:

No Source of funding

研究疾病:

颌骨缺损  

Target disease:

Jaw defect

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

本研究的目的是应用QCT测量颌骨重建患者术后移植骨的BMD变化,观察分析BMD是否随着时间发生改变以及与时间是否存在线性关系,BMD变化与性别,年龄是否有着一定的联系。讨论不同缺损部位的患者,例如上颌骨/下颌骨缺损,以及应用不同方式比如腓骨/髂骨进行修复是否都会对术后的BMD变化产生影响。  

Objectives of Study:

The purpose of this study was to use QCT to measure the changes in BMD of bone grafts after jaw reconstruction, observe and analyze whether BMD changes over time and whether there is a linear relationship with time, and whether BMD changes are associated with gender and age. Discuss if patients with different sites of defect, such as maxillary/mandibular defects, and different methods of repair, such as fibula/iliac crest, influence postoperative BMD changes.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 术后发生钛板暴露、感染以及皮瓣未成活等治疗失败者; 2. 患者患有骨代谢疾病; 3. 因某些原因无法接受CT检测的患者。

Exclusion criteria:

1. Failure of titanium plate exposure, infection and non-survival of skin flap after operation; 2. The patient suffers from bone metabolic disease; 3. Patients who cannot receive CT detection for some reasons.

研究实施时间:

Study execute time:

From 2023-01-01 00:00:00 To 2026-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-01-01 00:00:00 To 2026-12-31 00:00:00

干预措施:

Interventions:

组别:

颌骨缺损组

样本量:

300

Group:

Jaw defect group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

海淀 

Country:

China

Province:

Beijing

City:

Haidian

单位(医院):

北京大学口腔医院 

单位级别:

三甲 

Institution
hospital:

Peking University School and Hospital of Stomatology

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

性别

指标类型:

次要指标

Outcome:

Sex

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

年龄

指标类型:

次要指标

Outcome:

Age

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

缺损部位

指标类型:

次要指标

Outcome:

Sites of defect

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患侧重建颌骨BMD值

指标类型:

主要指标

Outcome:

Bone mineral density of reconstructed jaw

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

姓名

指标类型:

次要指标

Outcome:

Name

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

病历号

指标类型:

次要指标

Outcome:

Patient ID

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术日期

指标类型:

次要指标

Outcome:

Surgery date

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

复查日期

指标类型:

次要指标

Outcome:

Follow-up date

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

颌骨重建方式

指标类型:

主要指标

Outcome:

Reconstruction method

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

健侧颌骨BMD值

指标类型:

次要指标

Outcome:

Bone mineral density of normal jaw

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

放疗情况

指标类型:

次要指标

Outcome:

Condition of radiotherapy

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

种植情况

指标类型:

次要指标

Outcome:

Condition of implantation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 0 years
最大 Max age 100 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

本研究不进行随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

Random classification was not performed in this study

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

临床试验公共管理平台:http://www.medresman.org.cn/

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Clinical Trial Management Public Platform: http://www.medresman.org.cn/

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

六元空间临床大数据平台

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

H6WORLD Clinical Big Data Platform Features

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-03-22 17:46:12